SOURCE: Kalorama Information

Kalorama Information

December 15, 2010 10:06 ET

Opportunity in German Healthcare Market for Drug Makers: Kalorama

NEW YORK, NY--(Marketwire - December 15, 2010) - Widespread opportunities for healthcare manufacturers and drug makers define the $285 billion-dollar German healthcare market, according to two reports recently released by healthcare market research publisher Kalorama Information. The publisher predicts a $2.5 billion-dollar market for diabetes treatments and a $2.7 billion-dollar market for vaccines in Germany, as detailed in "The World Market for Diabetes Treatments" and "European Vaccine Markets."

The most populated nation in Europe, with over 81 million, Germany also has the highest prevalence rate of Type 2 diabetes in the major healthcare markets, attributed to national dietary and exercise habits. As in the United States, diet and exercise initiatives have been insufficient alone to stem the tide of cases, and medical intervention is often necessary. Kalorama details growth in vaccine sales is credited to an aging population and diseases, such as influenza, which significantly affects the population.

Germany has the oldest universal health system in the industrialized world and spends slightly more than France or the UK per person, with 2007 estimates at over $3500 per person. The system is a multi-layered approach with private companies providing standard medical insurance and long-term care under strict government regulation.

"It's the largest target market in Europe," said Bruce Carlson, publisher of Kalorama Information. "There are health issues in its population and a national consensus to fund healthcare. This makes it an attractive market for pharmaceutical companies."

Kalorama Information's report "European Vaccine Markets" provides vaccine markets for several European countries, as well as top products and market share. Information about the report can be found at: http://www.kaloramainformation.com/redirect.asp?progid=80165&productid=2833006

"The World Market for Diabetes Treatments" covers insulin and oral hypoglycemic markets around the world, and includes profiles of several companies in the market. The report can be found at: http://www.kaloramainformation.com/redirect.asp?progid=80165&productid=2809047.

About Kalorama Information
Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter (http://www.twitter.com/KaloramaInfo) and LinkedIn (http://www.linkedin.com/groups?gid=2177845&trk=hb_side_g).

Contact Information